THE SCHEDULE 13G

Company

Syndax Pharmaceuticals Inc

Filed

November 29, 2018

Accession Number

0000921895-18-003173

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →